1,3-diethyldiphenylurea

Endpoint summary

Key value for chemical safety assessment

Skin sensitisation

Link to relevant study records

Reference

Endpoint:

skin sensitisation: in vivo (LLNA)

Type of information:

experimental study

Adequacy of study:

key study

Study period:

31.10.-18.11.2011

Reliability:

1 (reliable without restriction)

Rationale for reliability incl. deficiencies:

guideline study

Qualifier:

according to guideline

Guideline:

EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)

Deviations:

no

GLP compliance:

yes

Type of study:

mouse local lymph node assay (LLNA)

Species:

mouse

Strain:

Balb/c

Sex:

female

Details on test animals and environmental conditions:

TEST ANIMALS
- Source: Breeding farm VELAZ s.r.o., Koleč u Kladna, Czech Republic
- Age at study initiation: 8-10 weeks
- Weight at study initiation: 16.6-19.22 g
- Housing: maximum six animals in macrolon cages with sterilized softwood shavings
- Diet (e.g. ad libitum): Pelleted standard diet for experimental animals ad libitum
- Water (e.g. ad libitum): Drinking tap water ad libitum
- Acclimation period: at least 5days

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 +/- 3°C, permanently monitored
- Humidity (%): 30 – 70 %, permanently monitored
- Air changes (per hr): approximately 15 air changes per hours
- Photoperiod (hrs dark / hrs light): 12 hours light/dark cycle

STUDY TIME SCHEDULE
Animal arrival/ start of acclimatization: 12. 10. 2011
Pilot experiment: 31.10.- 3.11. 2011

Main study:
First day of administration: 9.11.2011
End of treatment period: 11.11.2011
Application of radionuclide and necropsy: 14.11.2011

Vehicle:

other: DAE 433 - mixture of 40% dimethylacetamide, 30% acetone and 30% ethanol

Concentration:

The test substance was administered in the form of suspension in DAE 433.
Concentration in formulation:
30% (w/v) - 300 mg/mL
3% (w/v) - 30 mg/mL
0.3% (w/v) - 3 mg/mL

No. of animals per dose:

5 animals

Details on study design:

PILOT EXPERIMENT
The highest concentration 30% (maximum technically practicable concentration) was administered to three animals to assess and/or discard a possible systemic toxicity or high irritation of skin. During the pilot experiment no test item related effects were found in all three animals, respectively no clinical symptoms of systemic toxicity and no macroscopic changes (after necropsy) were detected.

MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
Animals were subjected to a clinical examination (health check) shortly after arrival. No clinical changes were recorded.
Study animals were randomly allocated to the dose groups manually and assigned animal numbers.

TREATMENT PREPARATION AND ADMINISTRATION:
Dosage volume: 25μL / ear / animal
Preparation for administration: All suspensions were prepared by mixing an appropriate amount of test substance and the vehicle to obtain the application form in concentration of 30%, 3% or 0.3% (w/v). The suspensions were prepared before the start of application by mixing on magnetic stirrer and then were still mixed during application.
Frequency of preparation: On each day immediately before administration.

IN VIVO EXAMINATION
- mortality
- clinical observation
- body weight

POST MORTEM INVESTIGATIONS
- ears weights
- incorporation of 3H-methyl thymidine

DATA ANALYSIS
Mean values and standard deviations of ears weight and incorporation of 3H-methyl thymidine were computed for the test item groups and for the positive as well as the vehicle control group. Stimulation index (for incorporation of 3H-methyl thymidine) was calculated by dividing mean values from the test substance groups and the positive control group by the corresponding mean value of the vehicle control group. The index for the vehicle control group was set at 1 by definition.

Positive control substance(s):

other: dinitrochlorobenzene (DNCB)

Statistics:

For statistical calculations the software Statgraphic ® Centurion (version XV, USA) was used. Statistical evaluation of measured parameters was performed at first by applying the non-parametric Kruskal-Wallis test for the comparison of the measured effect in all treatment groups with the vehicle control group, as global test, and then the non-parametric two-group Mann-Whitney rank test (probability level 0.05) for all two-group comparisons.

Positive control results:

The positive control substance DNCB produced positive LLNA response at an exposure level expected to give an increase in the Stimulation Index SI ≥ 3 over the negative control group, which was in congruence with the expected mode of action of a contact allergen. The positive control also elicited a reaction pattern with statistically significant increase in ear weight.
These results demonstrate that the method performed in conditions of laboratory has sufficient reliability.

Parameter:

SI

Value:

0.93

Test group / Remarks:

30%

Parameter:

SI

Value:

1.41

Test group / Remarks:

3%

Parameter:

SI

Value:

1.03

Test group / Remarks:

0.3%

Table 6.  Summary of results

Group	Radioisotope incorporation		Ear weight
	Mean DPM	SI	Mean (mg)
NC	252.80	1.00	22,98
PC	3393.15	13.42+	36,12*
30%	235.35	0.93	23,50
3%	356.31	1.41	23,50
0.3%	267.84	1.06	23,00

Figures with asterisk = values statistically significant on probability level < 0.05 (Mann-Whitney test)

Figures with cross = values ≥ 3

NC – Negative control group

PC – Positive control group

DISCUSSION

The animals exposed to the test substance showed no skin reactions and clinical symptoms of intoxication throughout the experiment.

The test substance did not show a tendency to increase ear weight – it means the test substance did not cause irritation of skin.

The comparison of the Stimulation Indexes between the treated groups and the control group revealed that the test substance did not cause a significant increase in radioisotope incorporation into the DNA of dividing lymphocytes.

Interpretation of results:

not sensitising

Remarks:

Migrated information Criteria used for interpretation of results: EU

Conclusions:

Under the given test conditions, the test substance, Centralit, does not elicit sensitising response in LLNA assay.

Executive summary:

The test substance, Centralit, was tested for the assessment of skin sensitisation potential with the murine local lymph node assay. This study is a part of the test substance health hazard evaluation. The Local Lymph Node Assay (LLNA) with radionuclides was used. The testing was conducted according to the EU Method B.42, Skin sensitization: Local Lymph Node Assay, Council Regulation (EC) No. 440/2008, published in O.J. L142, 2008.

In this study the contact allergenic potential of Centralit was evaluated after topical application to female BALB/c mice. Five mice per group were exposed on the dorsum of both ears once a day by test substance and control substances during 3 consecutive days. Primary proliferation of lymphocytes in the lymph node draining the site of application was evaluated on the base on using of radioactive labelling. The ratio of the proliferation in treated groups to that in vehicular controls, termed the Stimulation Index, was determined. Statistical evaluation of ear weight was performed for elimination of false positive findings with certain skin irritants.

Concentrations: positive control DNCB (dinitrochlorobenzene): 0.5% (w/v) and Centralit: 30%, 3%, 0.3% (w/v) in DAE 433.

The animals exposed to the test substance at all concentrations showed no pathological skin reactions and no other negative clinical symptoms of intoxication throughout the experiment. There was no significant difference in body weight increment of all groups in comparison to the vehicle control.

The positive control substance DNCB elicited a reaction pattern with statistically significant increase in ear weight and Stimulation Index of cell proliferation 13.42, which was in congruence with his expected mode of action as a contact allergen.

The test substance did not show a tendency to increased ear weight in any of concentrations tested. The result of skin irritation effect was considered as negative – it means the test substance did not cause irritation of skin.

Comparison of Stimulation Indexes between all treated groups and control vehicle group revealed that the test substance Centralit did not cause significant increase in radioisotope incorporation into the DNA of dividing lymphocytes.

In conclusion, at the given experimental conditions the test substance Centralit provided a negative result in LLNA test.

Endpoint conclusion

Endpoint conclusion:

no adverse effect observed (not sensitising)

Additional information:

The test substance, Centralit, was tested for the assessment of skin sensitisation potential with the murine local lymph node assay. The Local Lymph Node Assay (LLNA) with radionuclides was used.

The test substance did not show a tendency to increased ear weight in any of concentrations tested. The result of skin irritation effect was considered as negative – it means the test substance did not cause irritation of skin.Comparison of Stimulation Indexes between all treated groups and control vehicle group revealed that the test substance Centralit did not cause significant increase in radioisotope incorporation into the DNA of dividing lymphocytes.In conclusion, the test substance Centralit provided a negative result in LLNA test.

Migrated from Short description of key information:
The test substance Centralit provided a negative result in LLNA test at the given experimental conditions.

Justification for selection of skin sensitisation endpoint:
Only one study available

Justification for classification or non-classification

Based on the available data, the substance is not classified.